Telemonitoring of outpatients with heart failure: A search for the Holy Grail?

Circulation

Volumn 125, Issue 24, 2012, Pages 2965-2967

  Van Veldhuisen, Dirk J ^a   Maass, Alexander H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; EDITORIAL; HEALTH CARE UTILIZATION; HEART FAILURE; HEART LEFT VENTRICLE PRESSURE; HOME CARE; HOSPITALIZATION; HUMAN; LUNG ARTERY PRESSURE; MEDICAL DEVICE; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT MONITORING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TELEMONITORING;

DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; INTERNET; MALE; QUALITY OF HEALTH CARE;

EID: 84862539425     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.118141     Document Type: Editorial

References (17)

1. Hasan A, Paul V. Telemonitoring in chronic heart failure. Eur Heart J. 2011;32:1457-1464.
2. Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JGF. Which components of heart failure programs are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: abridged Cochrane Review. Eur J Heart Fail. 2011;13:1028-1040.
3. Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet. 2011;378:731-739.
4. Desai AS. Home monitoring heart failure care does not improve patient outcomes. Circulation. 2012;125:828-836.
5. Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363:2301-2309.
6. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, Boll H, Baumann G, honold M, Koehler K, Gelbrich G, Kirwan BA, Anker SD, on behalf of the TIM-HF Investigators. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation. 2011;123:1873-1880.
7. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF Study. J Am Coll Cardiol. 2008;51:1073-1079. (Pubitemid 351374766)
8. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS, for the CHAMPION trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658-666.
9. Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT, on behalf of the Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) Study Group. Physician-directed patients self-management of left atrial pressure in advanced chronic heart failure. Circulation. 2010;121:1086-1095.
10. Van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, Van Gelder IC, Dickstein K, Swedberg K. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail. 2009;11:1143-1151.
11. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, Van Veldhuisen DJ. 2010 Focused update of the ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Rhythm Association. Eur Heart J. 2010;31:2677-2687.
12. Whellan DJ, Ousdigian KT, Al-Khatib M, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM, for the PARTNERS Study Investigators. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations. Results from PARTNERS-HF (Program to access and review trending information and evaluate correlation to symptoms in patients with heart failure) Study. J Am Coll Cardiol. 2010;55:1803-1810.
13. Conraads V, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, Cowie MR. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations. Eur Heart J. 2011;32:2266-2273.
14. Van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie M, Jondeau G, Kautzner J, Aguilera RM, Lunati M, Yu CM, Gerritse B, Borggrefe M, on behalf of the DOT-HF Investigators. Intrathoracic impedance, audible patient alerts, and outcome in heart failure. Circulation. 2011;124:1719-1726.
15. Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, Parati G, Borghi G, Zanaboni P, Valsecchi S, Marzegalli M. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) study. Circulation. 2012;125:2985-2992.
16. Konstam MA. Home monitoring should be the central element in an effective program of heart failure disease management. Circulation. 2012;125:820-827.
17. Udelson JE. T.M.I. (Too much information)? Circulation. 2011;124: 1697-1699.